Complement blockade in ANCA-associated vasculitis: an index case, current concepts and future perspectives
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complement blockade in ANCA-associated vasculitis: an index case, current concepts and future perspectives
Authors
Keywords
ANCA, Vasculitis, Glomerulonephritis, Complement, Eculizumab
Journal
Internal and Emergency Medicine
Volume 12, Issue 6, Pages 727-731
Publisher
Springer Nature
Online
2017-02-13
DOI
10.1007/s11739-017-1636-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
- (2016) M Yates et al. ANNALS OF THE RHEUMATIC DISEASES
- Circulating C3 levels predict renal and global outcome in patients with renal vasculitis
- (2016) Javier Villacorta et al. CLINICAL RHEUMATOLOGY
- Glomerular C3d as a novel prognostic marker for renal vasculitis
- (2016) Javier Villacorta et al. HUMAN PATHOLOGY
- Diagnosis of complement alternative pathway disorders
- (2016) Andrea Angioi et al. KIDNEY INTERNATIONAL
- Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosis
- (2016) Shoichi Fukui et al. MEDICINE
- MO039SUCCESSFUL STEROID REPLACEMENT IN ANCA-ASSOCIATED VASCULITIS WITH C5A RECEPTOR INHIBITOR CCX168 IN PHASE 2 RANDOMISED TRIAL (CLEAR)
- (2016) David Jayne et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Management of Small Vessel Vasculitides
- (2016) Giuseppe Lopalco et al. Current Rheumatology Reports
- Low Serum Complement C3 Levels at Diagnosis of Renal ANCA-Associated Vasculitis Is Associated with Poor Prognosis
- (2016) Jean-François Augusto et al. PLoS One
- Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis
- (2015) L. Manenti et al. Clinical Journal of the American Society of Nephrology
- Emergency testing for antineutrophil cytoplasmic antibodies combined with a dialog-based policy between clinician and biologist: effectiveness for the diagnosis of ANCA-associated vasculitis
- (2014) Johnny Sayegh et al. Internal and Emergency Medicine
- Association of Low Serum Complement C3 with Reduced Patient and Renal Survival in Antimyeloperoxidase-Associated Small-Vessel Vasculitis
- (2014) Yair Molad et al. NEPHRON CLINICAL PRACTICE
- With Complements from ANCA Mice
- (2013) R. Kettritz JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
- (2013) H. Xiao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody–associated vasculitis
- (2012) Shen-Ju Gou et al. KIDNEY INTERNATIONAL
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement Activation Is Involved in Renal Damage in Human Antineutrophil Cytoplasmic Autoantibody Associated Pauci-Immune Vasculitis
- (2008) Guang-qun Xing et al. JOURNAL OF CLINICAL IMMUNOLOGY
- C5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis
- (2008) A. Schreiber et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis
- (2008) M. Chen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started